Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients
Gespeichert in:
| Veröffentlicht in: | Cancer chemotherapy and pharmacology 1979-01, Vol.3 (3), p.161 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 3 |
| container_start_page | 161 |
| container_title | Cancer chemotherapy and pharmacology |
| container_volume | 3 |
| creator | Evans, W E Pratt, C B Taylor, R H Barker, L F Crom, W R |
| description | |
| doi_str_mv | 10.1007/BF00262416 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF00262416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>316744</sourcerecordid><originalsourceid>FETCH-LOGICAL-c240t-1cb0da3225707af71fb498b36b56ecb64cd6416668b6888ee8f313cf4596b4173</originalsourceid><addsrcrecordid>eNpF0D1PwzAQgGEL8RUKCzNDZqSUc3x13BGqFpAqwQAjimzHbkybuLKNRP89QUVluuXR6e4l5JrCmAJUdw8LgJKXSPkRySiysgCB7JhkwBCLSQV4Ti5i_AQApIydkVNGeYWYkY_XVoZOar92vUlO553vXfLB9avc27x1q7ZofDR5Z1LrUzDfMplxPpdhs8uD0X41cOf7Aw4urvOtTM70KV6SEys30Vz9zRF5X8zfZk_F8uXxeXa_LHSJkAqqFTSSleVwaSVtRa3CqVCMqwk3WnHUDR9-41woLoQwRlhGmbY4mXKFtGIjcrvfq4OPMRhbb4PrZNjVFOrfQvV_oQHf7PH2S3WmOdB9EvYDr5dhJA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Evans, W E ; Pratt, C B ; Taylor, R H ; Barker, L F ; Crom, W R</creator><creatorcontrib>Evans, W E ; Pratt, C B ; Taylor, R H ; Barker, L F ; Crom, W R</creatorcontrib><identifier>ISSN: 0344-5704</identifier><identifier>EISSN: 1432-0843</identifier><identifier>DOI: 10.1007/BF00262416</identifier><identifier>PMID: 316744</identifier><language>eng</language><publisher>Germany</publisher><subject>Bone Neoplasms - drug therapy ; Drug Therapy, Combination ; Half-Life ; Humans ; Kinetics ; Leucovorin - therapeutic use ; Methotrexate - administration & dosage ; Methotrexate - adverse effects ; Methotrexate - metabolism ; Methotrexate - therapeutic use ; Osteosarcoma - drug therapy ; Risk ; Time Factors</subject><ispartof>Cancer chemotherapy and pharmacology, 1979-01, Vol.3 (3), p.161</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/316744$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Evans, W E</creatorcontrib><creatorcontrib>Pratt, C B</creatorcontrib><creatorcontrib>Taylor, R H</creatorcontrib><creatorcontrib>Barker, L F</creatorcontrib><creatorcontrib>Crom, W R</creatorcontrib><title>Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients</title><title>Cancer chemotherapy and pharmacology</title><addtitle>Cancer Chemother Pharmacol</addtitle><subject>Bone Neoplasms - drug therapy</subject><subject>Drug Therapy, Combination</subject><subject>Half-Life</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Leucovorin - therapeutic use</subject><subject>Methotrexate - administration & dosage</subject><subject>Methotrexate - adverse effects</subject><subject>Methotrexate - metabolism</subject><subject>Methotrexate - therapeutic use</subject><subject>Osteosarcoma - drug therapy</subject><subject>Risk</subject><subject>Time Factors</subject><issn>0344-5704</issn><issn>1432-0843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1979</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0D1PwzAQgGEL8RUKCzNDZqSUc3x13BGqFpAqwQAjimzHbkybuLKNRP89QUVluuXR6e4l5JrCmAJUdw8LgJKXSPkRySiysgCB7JhkwBCLSQV4Ti5i_AQApIydkVNGeYWYkY_XVoZOar92vUlO553vXfLB9avc27x1q7ZofDR5Z1LrUzDfMplxPpdhs8uD0X41cOf7Aw4urvOtTM70KV6SEys30Vz9zRF5X8zfZk_F8uXxeXa_LHSJkAqqFTSSleVwaSVtRa3CqVCMqwk3WnHUDR9-41woLoQwRlhGmbY4mXKFtGIjcrvfq4OPMRhbb4PrZNjVFOrfQvV_oQHf7PH2S3WmOdB9EvYDr5dhJA</recordid><startdate>19790101</startdate><enddate>19790101</enddate><creator>Evans, W E</creator><creator>Pratt, C B</creator><creator>Taylor, R H</creator><creator>Barker, L F</creator><creator>Crom, W R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19790101</creationdate><title>Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients</title><author>Evans, W E ; Pratt, C B ; Taylor, R H ; Barker, L F ; Crom, W R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c240t-1cb0da3225707af71fb498b36b56ecb64cd6416668b6888ee8f313cf4596b4173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1979</creationdate><topic>Bone Neoplasms - drug therapy</topic><topic>Drug Therapy, Combination</topic><topic>Half-Life</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Leucovorin - therapeutic use</topic><topic>Methotrexate - administration & dosage</topic><topic>Methotrexate - adverse effects</topic><topic>Methotrexate - metabolism</topic><topic>Methotrexate - therapeutic use</topic><topic>Osteosarcoma - drug therapy</topic><topic>Risk</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Evans, W E</creatorcontrib><creatorcontrib>Pratt, C B</creatorcontrib><creatorcontrib>Taylor, R H</creatorcontrib><creatorcontrib>Barker, L F</creatorcontrib><creatorcontrib>Crom, W R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Cancer chemotherapy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Evans, W E</au><au>Pratt, C B</au><au>Taylor, R H</au><au>Barker, L F</au><au>Crom, W R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients</atitle><jtitle>Cancer chemotherapy and pharmacology</jtitle><addtitle>Cancer Chemother Pharmacol</addtitle><date>1979-01-01</date><risdate>1979</risdate><volume>3</volume><issue>3</issue><spage>161</spage><pages>161-</pages><issn>0344-5704</issn><eissn>1432-0843</eissn><cop>Germany</cop><pmid>316744</pmid><doi>10.1007/BF00262416</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0344-5704 |
| ispartof | Cancer chemotherapy and pharmacology, 1979-01, Vol.3 (3), p.161 |
| issn | 0344-5704 1432-0843 |
| language | eng |
| recordid | cdi_crossref_primary_10_1007_BF00262416 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Bone Neoplasms - drug therapy Drug Therapy, Combination Half-Life Humans Kinetics Leucovorin - therapeutic use Methotrexate - administration & dosage Methotrexate - adverse effects Methotrexate - metabolism Methotrexate - therapeutic use Osteosarcoma - drug therapy Risk Time Factors |
| title | Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T18%3A43%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetic%20monitoring%20of%20high-dose%20methotrexate.%20Early%20recognition%20of%20high-risk%20patients&rft.jtitle=Cancer%20chemotherapy%20and%20pharmacology&rft.au=Evans,%20W%20E&rft.date=1979-01-01&rft.volume=3&rft.issue=3&rft.spage=161&rft.pages=161-&rft.issn=0344-5704&rft.eissn=1432-0843&rft_id=info:doi/10.1007/BF00262416&rft_dat=%3Cpubmed_cross%3E316744%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/316744&rfr_iscdi=true |